Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Compact Immunoanalyzer Gains CE Mark for Testing Across Local Care Settings

By LabMedica International staff writers
Posted on 28 Oct 2026

Smaller clinics and laboratories must deliver reliable results despite limited infrastructure, outsourcing delays, and workforce shortages. More...

These pressures highlight the need for consistent immunoassay testing across cardiometabolic, oncology, and infectious disease applications. A new compact immunoanalyzer from Roche aims to meet these needs in decentralized laboratories.

Roche has received the CE mark for the cobas smart e immunoanalyzer, a compact standalone platform engineered to deliver central-laboratory performance in a footprint of less than one square meter. As the newest member of the cobas immunoassay testing family, it is intended to complement the cobas e 402 and cobas e 801 analytical units. These units run up to 120 and 300 tests per hour, respectively, while the cobas smart e processes up to 60 tests per hour.

The cobas smart e shares the universal reagent carriers and Elecsys technology used by Roche’s high-throughput central laboratory platforms. It accommodates 36 reagent positions and has a planned menu of more than 100 high-medical-value assays spanning cardiometabolic, oncology, infectious diseases, and other disease areas. More than 90% of Roche immunoassays have reaction times of 18 minutes or less, with routine testing on the system also completed using reaction times of 18 minutes or less.

Alongside these testing capabilities, the system is designed to reduce hands-on laboratory work through guided, step-by-step tasks and minimal maintenance requirements. According to Roche, it requires one minute of daily operator intervention and reduces hands-on maintenance by up to two-thirds compared with previous-generation platforms. A load of 36 samples provides up to two hours of walk-away time, while an integrated water tank, standard power compatibility, and a dust-protection design support operation in more challenging environments.

The platform is positioned to support small local clinics, decentralized sites, and larger hospital laboratory networks using comparable immunoassay results across locations. Roche also notes that the planned assay menu will be launched in sequential waves. Additional information is being presented at the International Federation of Clinical Chemistry (IFCC) World Congress in New Delhi, India, from October 25-29, 2026.

“For smaller hospitals and laboratories, maintaining central-lab quality has traditionally meant outsourcing tests. The cobas smart e immunoanalyser fits on a benchtop, bringing Roche's immunoassay standards directly into these care settings. This means our cobas immunoassay solutions now span the full range of healthcare settings while delivering consistent high-quality results, ensuring patients get timely, accurate answers, no matter where they live," said Matt Sause, CEO of Roche Diagnostics.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.